Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: The CLASP IID 2-Year RCT and Registry Outcomes
Author(s): Firas Zahr Added: 6 months ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more

Intervention
EuroPCR 23: DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation
Author(s): D Scott Lim Added: 2 years ago
EuroPCR 23 - Dr Scott Lim (UVA Health Heart and Vascular Center, US) joins us to discuss the findings of the DRAGONFLY-DMR trial. (NCT04734756) The purpose of the study was to assess the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system (Hangzhou Valgen Medtech) for treating symptomatic moderate-to-severe (3+) or severe (4+) degenerative mitral regurgitation (DMR… View more

Intervention
Left Atrium Role in Secondary Mitral Regurgitation
Author(s): Markos Koukos , Yannis Dimitroglou , Dimitrios Tsartsalis , et al Added: 1 year ago

Vascular Disease and Surgery

Imaging & Diagnostics
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 6 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
Atrioventricular (AV) Valves Summit 2023
Author(s): , Added: 1 year ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more

Imaging & Diagnostics

Intervention
Atrioventricular (AV) Valves Summit 2024
Author(s): Marco Metra , Victoria Delgado , Nicole Karam , et al Added: 6 months ago
In this series of short interviews filmed at AV Valves Summit 2024, leading experts offer valuable insights and professional opinions on transcatheter mitral and tricuspid interventions.The sessions explore a wide array of topics, including advancements in TEER techniques, the evolving focus on patient quality of life, the ongoing debate between repair versus replacement, and the most effective… View more

Vascular Disease and Surgery
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
Author(s): Didier Tchétché Added: 6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more

Demographic

Intervention
TCT 24: The TAVR UNLOAD Trial
Author(s): Nicolas M Van Mieghem Added: 6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)… View more

Heart Failure

Intervention
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention
Dr Gilbert Tang is Surgical Director of the Structural Heart Program at the Mount Sinai Health System and Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai in New York. He has performed over 2000 cases of transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement, and tricuspid valve repair… View more